Cost Of Revenue - Vimian Group AB (STO:VIMIAN) - Alpha Spread
V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 43.7 SEK 1.63% Market Closed
Market Cap: 22.6B SEK
Have any thoughts about
Vimian Group AB?
Write Note

Vimian Group AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vimian Group AB
Cost of Revenue Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
S
S2M

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
V
Vimian Group AB
STO:VIMIAN
Cost of Revenue
-€182m
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Cost of Revenue
-kr28.5m
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Cost of Revenue
-kr180.5m
CAGR 3-Years
-43%
CAGR 5-Years
-28%
CAGR 10-Years
-27%
D
Doxa AB
STO:DOXA
Cost of Revenue
-kr5.1m
CAGR 3-Years
23%
CAGR 5-Years
25%
CAGR 10-Years
12%
Bactiguard Holding AB
STO:BACTI B
Cost of Revenue
-kr161.9m
CAGR 3-Years
-24%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Cost of Revenue
-kr1.1m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vimian Group AB's Cost of Revenue?
Cost of Revenue
-182m EUR

Based on the financial report for Jun 30, 2024, Vimian Group AB's Cost of Revenue amounts to -182m EUR.

What is Vimian Group AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-64%

Over the last year, the Cost of Revenue growth was -61%. The average annual Cost of Revenue growth rates for Vimian Group AB have been -64% over the past three years .

Back to Top